Provided by Tiger Fintech (Singapore) Pte. Ltd.

Applied Therapeutics Inc.

0.2842
+0.065930.19%
Post-market: 0.31000.0258+9.08%17:28 EST
Volume:313.21M
Turnover:100.54M
Market Cap:41.01M
PE:-0.60
High:0.4000
Open:0.2520
Low:0.2211
Close:0.2183
52wk High:10.48
52wk Low:0.2182
Shares:144.30M
Float Shares:120.21M
Volume Ratio:17.04
T/O Rate:260.54%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4752
EPS(LYR):-0.7570
ROE:-150.82%
ROA:-84.32%
PB:2.35
PE(LYR):-0.38

Loading ...

Dec 11, 2023

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Dec 06, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Nov 17, 2023

Major Issues Report

Form 8-K - Current report
Nov 13, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Nov 09, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2023

Major Issues Report

Form 8-K - Current report
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 03, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 01, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Oct 14, 2023

Major Issues Report

Form 8-K - Current report
Sep 06, 2023

Major Issues Report

Form 8-K - Current report
Aug 11, 2023

Major Issues Report

Form 8-K - Current report
Aug 10, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 16, 2023

Major Issues Report

Form 8-K - Current report
Jun 06, 2023

Major Issues Report

Form 8-K - Current report
May 17, 2023

Correspondence

Form CORRESP - Correspondence
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report